My gut: suspension ad Infinitum is totally fine and dandy with the leadership of GMV. They're in no hurry to answer the ASX -- based on the belief that ASX will not delist them, out of consideration for shareholders. I suspect Brendan and Yacov are hoping -- wishfully, passively, possibly curled up in a ball -- for an against-the-odds lottery windfall from NMPA/CFDA. That and only that will trigger a return from suspension. Because limbo at 8c is better than free fall to 0.1c. LT holders -- don't hold your breath.
(Obviously, I'd LOVE to be wrong. But I find it implausible after the last year that corporate competence or nous or ingenuity will suddenly become part of their skill set.)
- Forums
- ASX - By Stock
- GMV
- Ann: Response to ASX Query
Ann: Response to ASX Query, page-156
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online